| Metric | Q3 2020 | Q2 2020 | Q3 2019 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $1.2B | $1.1B | $1.3B | 4.4% | -10.7% |
| Op. Income | $44M | -$305M | $439M | 114.4% | -90.0% |
| Gross Margin | 48.9% | 15.9% | 70.6% | 33.0pp | -21.7pp |
| Net Margin | 2.5% | -15.8% | 23.8% | 18.3pp | -21.2pp |
| EPS (Diluted) | $0.38 | $-2.25 | $3.96 | 117.0% | -90.4% |
| Free Cash Flow | -$2.7B | $16M | $41M | -16305.4% | -6549.6% |
| Item | Amount |
|---|---|
| REVENUE | $1.2B |
| Cost of Revenue | $606M |
| GROSS PROFIT | $580M |
| R&D Expenses | $0 |
| Selling & Marketing | $26M |
| General & Administrative | $308M |
| SG&A Expenses | $334M |
| Other Expenses | $202M |
| Operating Expenses | $536M |
| Cost & Expenses | $1.1B |
| OPERATING INCOME | $44M |
| Interest Income | $851M |
| Interest Expense | $229M |
| Other Income/Expenses | $0 |
| INCOME BEFORE TAX | $44M |
| Income Tax Expense | $16M |
| NET INCOME | $30M |
| D&A | $48M |
| EBIT | $44M |
| EBITDA | $92M |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| REVENUE | $1.2B |
| Cost of Revenue | $606M |
| GROSS PROFIT | $580M |
| R&D Expenses | $0 |
| Selling & Marketing | $26M |
| General & Administrative | $308M |
| SG&A Expenses | $334M |
| Other Expenses | $202M |
| Operating Expenses | $536M |
| Cost & Expenses | $1.1B |
| OPERATING INCOME | $44M |
| Interest Income | $851M |
| Interest Expense | $229M |
| Other Income/Expenses | $0 |
| INCOME BEFORE TAX | $44M |
| Income Tax Expense | $16M |
| NET INCOME | $30M |
| D&A | $48M |
| EBIT | $44M |
| EBITDA | $92M |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| Net Income | $30M |
| Depreciation & Amortization | $49M |
| Stock-Based Compensation | $8M |
| Deferred Income Tax | $0 |
| Other Non-Cash Items | -$2.4B |
| Change in Working Capital | -$330M |
| OPERATING CASH FLOW | -$2.6B |
| Capital Expenditure | -$6M |
| Acquisitions (Net) | $0 |
| Purchases of Investments | $0 |
| Sales/Maturities of Investments | $0 |
| Other Investing Activities | $231M |
| NET CASH FROM INVESTING | $226M |
| Net Debt Issuance | $0 |
| Common Stock Repurchased | $0 |
| Common Dividends Paid | $0 |
| Other Financing Activities | $2.0B |
| NET CASH FROM FINANCING | $2.0B |
| FREE CASH FLOW | -$2.7B |
| Net Change in Cash | -$283M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $10.2B |
| Short-Term Investments | $11.8B |
| Net Receivables | $241M |
| Inventory | $0 |
| Other Current Assets | $0 |
| TOTAL CURRENT ASSETS | $22.2B |
| PP&E (Net) | $604M |
| Goodwill | $228M |
| Intangible Assets | $487M |
| Long-Term Investments | $42.9B |
| Tax Assets | $0 |
| Other Non-Current Assets | $577M |
| TOTAL NON-CURRENT ASSETS | $44.8B |
| TOTAL ASSETS | $66.9B |
| Account Payables | $64M |
| Short-Term Debt | $8.0B |
| Deferred Revenue | $0 |
| Other Current Liabilities | $39.7B |
| TOTAL CURRENT LIABILITIES | $47.8B |
| Long-Term Debt | $6.7B |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $0 |
| Other Non-Current Liabilities | $5.5B |
| TOTAL NON-CURRENT LIABILITIES | $12.2B |
| TOTAL LIABILITIES | $60.0B |
| Common Stock | $381M |
| Additional Paid-In Capital | $46M |
| Retained Earnings | -$87M |
| Treasury Stock | -$60M |
| Accum. Other Comp. Income | $354M |
| Other Equity | $6.2B |
| TOTAL STOCKHOLDERS' EQUITY | $6.8B |
| Minority Interest | $136M |
| TOTAL EQUITY | $7.0B |
| TOTAL LIABILITIES & EQUITY | $66.9B |
| Total Debt | $14.7B |
| Net Debt | $4.5B |
